Jilin Province Huinan Changlong Bio-pharmacy Co (FRA:JIL) Intrinsic Value: DCF (Earnings Based): €0.52 (As of Sep. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:JIL Jilin Province Huinan Changlong Bio-pharmacy Co Ltd FRA:JIL
45 GF Score
Price €0.24
GF Value €0.20
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Jilin Province Huinan Changlong Bio-pharmacy Co Intrinsic Value: DCF (Earnings Based)?

Jilin Province Huinan Changlong Bio-pharmacy Co FRA:JIL +0.83% 45 Intrinsic Value: DCF (Earnings Based) is €0.52 as of Sep. 15, 2026. GuruFocus rates FRA:JIL with a GF Score™ of 45/100 and a GF Value™ of €0.20 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 146 Drug Manufacturers companies, Jilin Province Huinan Changlong Bio-pharmacy Co ranks better than 82.88% on this metric.

As of today (2026-09-15), Jilin Province Huinan Changlong Bio-pharmacy Co's intrinsic value calculated from the Discounted Earnings model is €0.52.

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's predictability rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Jilin Province Huinan Changlong Bio-pharmacy Co's Predictability Rank is 2.5-Stars.

Margin of Safety (Earnings Based) using Discounted Earnings model for Jilin Province Huinan Changlong Bio-pharmacy Co is 53.08%.

The historical rank and industry rank for Jilin Province Huinan Changlong Bio-pharmacy Co's Intrinsic Value: DCF (Earnings Based) or its related term are showing as below:

FRA:JIL' s Price-to-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.08   Med: 0.16   Max: 0.88
Current: 0.43

During the past 13 years, the highest Price-to-Intrinsic-Value-DCF (Earnings Based) Ratio of Jilin Province Huinan Changlong Bio-pharmacy Co was 0.88. The lowest was 0.08. And the median was 0.16.

FRA:JIL's Price-to-DCF (Earnings Based) is ranked better than
82.88% of 146 companies
in the Drug Manufacturers industry
Industry Median: 0.955 vs FRA:JIL: 0.43

Jilin Province Huinan Changlong Bio-pharmacy Co  (FRA:JIL) Intrinsic Value: DCF (Earnings Based) Explanation

Unlike valuation methods such as Net Current Asset Value, Tangible Book Value per Share, Graham Number, Median Ratio etc, discounted Cash Flow model evaluates the companies based on their future earnings power instead of their assets.


Be Aware

What you need to know about Discounted Earnings model:

1. The Discounted Earnings model evaluates a company based on its future earnings power
2. Growth is taken into account; therefore a faster growth company is worth more if everything else is the same.
3. Since we are projecting future growth, it is assumed that the company will grow at the same rate as it did during the past 10 years. Therefore this model works better for the companies that are relatively consistent performers.
4. The Discounted Earnings model works poorly for inconsistent performers like cyclicals.
5. Your expected return from the investment is a reasonable discount rate assumption.
6. A larger margin of safety should be required for companies with less predictable businesses.

You can screen for stocks that trade below their Intrinsic Value: DCF (FCF Based) and Intrinsic Value: DCF (Earnings Based) with the GuruFocus All-in-One Screener. Companies with a high Predictability Rank that trade at a discount to their Intrinsic Value: DCF (FCF Based) and Intrinsic Value: DCF (Earnings Based) can be found in the screen of Undervalued Predictable Companies.


Jilin Province Huinan Changlong Bio-pharmacy Co Intrinsic Value: DCF (Earnings Based) Related Terms


Jilin Province Huinan Changlong Bio-pharmacy Co Intrinsic Value: DCF (Earnings Based) Historical Data

* Premium members only.

The historical data trend for Jilin Province Huinan Changlong Bio-pharmacy Co's Intrinsic Value: DCF (Earnings Based) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jilin Province Huinan Changlong Bio-pharmacy Co Intrinsic Value: DCF (Earnings Based) Chart

Jilin Province Huinan Changlong Bio-pharmacy Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Intrinsic Value: DCF (Earnings Based)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.47

Jilin Province Huinan Changlong Bio-pharmacy Co Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Intrinsic Value: DCF (Earnings Based) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.47 0.00

FRA:JIL vs ZTS: Intrinsic Value: DCF (Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Jilin Province Huinan Changlong Bio-pharmacy Co's Price-to-DCF (Earnings Based), along with its competitors' market caps and Price-to-DCF (Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jilin Province Huinan Changlong Bio-pharmacy Co Price-to-DCF (Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jilin Province Huinan Changlong Bio-pharmacy Co's Price-to-DCF (Earnings Based) distribution charts can be found below:

* The bar in red indicates where Jilin Province Huinan Changlong Bio-pharmacy Co's Price-to-DCF (Earnings Based) falls into.


FRA:JIL
45GF Score
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd FRA:JIL
Intrinsic Value: DCF (Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jilin Province Huinan Changlong Bio-pharmacy Co Intrinsic Value: DCF (Earnings Based) Calculation

This is the intrinsic value calculated from the Discounted Earnings model with default parameters. The calculation method is the same as Discounted Cash Flow model except earnings are used in the calculation instead of free cash flow. This is the default method of calculation with GuruFocus DCF calculator.

Usually a two-stage model is used in calculating the intrinsic value with discounted cash flow model. The first stage is called growth stage; the second is called the terminal stage. In the growth stage the company grows at a faster rate. Because it cannot grow at that rate forever, a lower rate is used for the terminal stage.

GuruFocus DCF calculator is a two-stage model. The default values are defined as:

1. Discount Rate: d = 12%
A reasonable discount rate assumption should be at least the long term average return of the stock market, which can be estimated from risk free rate plus risk premium of stock market. GuruFocus uses 10-Year Treasury Constant Maturity Rate as the risk-free rate and rounded up to the nearest integer. It is updated daily. The current risk-free rate is 5.02%. Please go to Economic Indicators page for more information. Please note that we use the 10-Year Treasury Constant Maturity Rate of the country/region where the company is headquartered. If the data for that country/region is not available, then we will use the 10-Year Treasury Constant Maturity Rate of the United States as default. Then we added a risk premium of 6% to get the estimated discount rate. Some investors use their expected rate of return, which is also reasonable. A typical discount rate can be anywhere between 6% - 20%.

2. Growth Rate in the growth stage: g1 = 5%
The Growth Rate in the growth stage is initially set as the default 10-Year EPS without NRI Growth Rate. In cases where the 10-year growth rate is unavailable, it defaults to using the 5-Year EPS without NRI Growth Rate. If both the 10-year and 5-year growth rates are unavailable, the system defaults to the 3-Year EPS without NRI Growth Rate.
However, it's important to note that there is a growth rate range. If the calculated growth rate exceeds 20%, it will be capped at 20%. Conversely, if the calculated growth rate falls below 5%, it will be adjusted to 5% to maintain a reasonable range.
=> Jilin Province Huinan Changlong Bio-pharmacy Co's average EPS without NRI Growth Rate in the past 10 years was 3.50%, which is less than 5%. GuruFocus defaults => Growth Rate: 5%

3. Years of Growth Stage: y1 = 10

4. Terminal Growth Rate: g2 = 4%

5. Years of Terminal Growth: y2 = 10

6. EPS without NRI: eps without nri = €0.049.
GuruFocus DCF calculator is actually a Discounted Earnings calculator, EPS without NRI is used as the default. The reason we are doing this is we found that historically stock prices are more correlated with earnings than free cash flow.

All of the default settings can be changed and the results are calculated automatically.

Jilin Province Huinan Changlong Bio-pharmacy Co's Intrinsic Value: DCF (Earnings Based) for today is calculated as:

Intrinsic Value: DCF (Earnings Based)=EPS without NRI*{[(1+g1)/(1+d)+(1+g1)^2/(1+d)^2+...+(1+g1)^10/(1+d)^10]
+(1+g1)^10/(1+d)^10*[(1+g2)/(1+d)+(1+g2)^2/(1+d)^2+...+(1+g2)^10/(1+d)^10]}

set x = (1+g1)/(1+d) = (1+0.05)/(1+0.12) = 0.9375
and y = (1+g2)/(1+d) = (1+0.04)/(1+0.12) = 0.92857142857143

Intrinsic Value: DCF (Earnings Based)=EPS without NRI*{[x+x^2+...+x^10]+x^10*[y+y^2+...+y^10]}
=EPS without NRI*[x*(1-x^10)/(1-x)+x^10*y*(1-y^10)/(1-y)]
=0.049*10.7016
=0.52

Margin of Safety % (DCF Earnings Based)=(Intrinsic Value: DCF (Earnings Based)-Current Price)/Intrinsic Value: DCF (Earnings Based)
=(0.52-0.244)/0.52
=53.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Intrinsic Value: DCF (Earnings Based) of €0.52 mean?
Jilin Province Huinan Changlong Bio-pharmacy Co (FRA:JIL) has a Intrinsic Value: DCF (Earnings Based) of €0.52 as of Sep. 15, 2026. Intrinsic Value: DCF (Earnings Based) is the stock value based on a two-stage discounted earnings model. View historical data on Jilin Province Huinan Changlong Bio-pharmacy Co and its competitors. According to the industry distribution chart, Jilin Province Huinan Changlong Bio-pharmacy Co ranks #25 out of 146 companies in the Drug Manufacturers industry, placing it in the top 17.1%.
Is Jilin Province Huinan Changlong Bio-pharmacy Co's Intrinsic Value: DCF (Earnings Based) too high?
Jilin Province Huinan Changlong Bio-pharmacy Co's current Intrinsic Value: DCF (Earnings Based) is €0.52. Based on the distribution chart, Jilin Province Huinan Changlong Bio-pharmacy Co ranks #25 out of 146 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Jilin Province Huinan Changlong Bio-pharmacy Co has a GF Score™ of 45/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jilin Province Huinan Changlong Bio-pharmacy Co's Intrinsic Value: DCF (Earnings Based) compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Jilin Province Huinan Changlong Bio-pharmacy Co ranks #25 out of 146 companies for Intrinsic Value: DCF (Earnings Based). This places Jilin Province Huinan Changlong Bio-pharmacy Co in the top 17% of its industry — outperforming the majority of peers. The industry median Intrinsic Value: DCF (Earnings Based) is 0.96. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Intrinsic Value: DCF (Earnings Based) for a Drug Manufacturers company?
The median Intrinsic Value: DCF (Earnings Based) among Drug Manufacturers companies is 0.96, based on 146 companies in the industry. Companies in the top quartile (top 25%) have a Intrinsic Value: DCF (Earnings Based) significantly above this median, while those in the bottom quartile fall well below. However, Intrinsic Value: DCF (Earnings Based) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Intrinsic Value: DCF (Earnings Based) mean?
A high Intrinsic Value: DCF (Earnings Based) can signal that a stock is expensive relative to its fundamentals. Intrinsic Value: DCF (Earnings Based) is the stock value based on a two-stage discounted earnings model. View historical data on Jilin Province Huinan Changlong Bio-pharmacy Co and its competitors. For the Drug Manufacturers industry, the median Intrinsic Value: DCF (Earnings Based) is 0.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jilin Province Huinan Changlong Bio-pharmacy Co's current Intrinsic Value: DCF (Earnings Based) is €0.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jilin Province Huinan Changlong Bio-pharmacy Co stock overvalued right now?
Based on GuruFocus' analysis, Jilin Province Huinan Changlong Bio-pharmacy Co (FRA:JIL) is currently considered Modestly Overvalued. The stock's GF Value™ is €0.20, compared to a current price of €0.24 — trading 22% above its estimated fair value. The current Intrinsic Value: DCF (Earnings Based) is €0.52. Jilin Province Huinan Changlong Bio-pharmacy Co's overall GF Score™ is 45/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Intrinsic Value: DCF (Earnings Based) calculated?
Intrinsic Value: DCF (Earnings Based) is calculated from a company's financial statements. For Jilin Province Huinan Changlong Bio-pharmacy Co (FRA:JIL), the current Intrinsic Value: DCF (Earnings Based) is €0.52 as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jilin Province Huinan Changlong Bio-pharmacy Co (FRA:JIL) Overvalued in 2026?

Based on GuruFocus' analysis, Jilin Province Huinan Changlong Bio-pharmacy Co stock appears to be overvalued. The current stock price of €0.24 is trading 22% above its estimated GF Value™ of €0.20. GuruFocus considers Jilin Province Huinan Changlong Bio-pharmacy Co to be Modestly Overvalued.

Key valuation signals for FRA:JIL:

  • Intrinsic Value: DCF (Earnings Based): €0.52
  • GF Value™: €0.20 vs. price of €0.24 (22% above fair value)
  • GF Score™: 45/100 with 2 warning signs

No single metric tells the full story. See the FRA:JIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jilin Province Huinan Changlong Bio-pharmacy Co Business Description

Other Exchanges 08049:Hong Kong
Address 625 & 639 Nathan Road, Room 1101-2, 11th Floor, Office Tower Two, Grand Plaza, Mong kok, Kowloon, Hong Kong, HKG
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd is principally engaged in the manufacture and distribution of Chinese medicines and pharmaceutical products in the PRC under the brand names of Changlong and Qing Tong. The company has only one business segment. It generates revenue from the Sales of Chinese medicines and pharmaceutical products. Geographically, it derives its entire revenue from the PRC.
45GF Score

Get the complete analysis for FRA:JIL

Intrinsic Value: DCF (Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.24
Price
€0.20
GF Value